scispace - formally typeset
S

Sophie Ohlsson

Researcher at Lund University

Publications -  37
Citations -  1899

Sophie Ohlsson is an academic researcher from Lund University. The author has contributed to research in topics: Anti-neutrophil cytoplasmic antibody & Vasculitis. The author has an hindex of 15, co-authored 34 publications receiving 1544 citations. Previous affiliations of Sophie Ohlsson include University of Copenhagen & Karolinska Institutet.

Papers
More filters
Journal ArticleDOI

Genetically Distinct Subsets within ANCA-Associated Vasculitis

TL;DR: This study confirms that the pathogenesis of ANCA-associated vasculitis has a genetic component, shows genetic distinctions between granulomatosis with polyang iitis and microscopic polyangiitis that are associated with ANCA specificity, and suggests that the response against the autoantigen proteinase 3 is a central pathogenic feature ofproteinase 3 ANCA -associated vasulitis.
Journal ArticleDOI

Genome-wide association study of eosinophilic granulomatosis with polyangiitis reveals genomic loci stratified by ANCA status.

TL;DR: A genome-wide association study of EGPA is described that reveals clinical and genetic differences between subgroups stratified by autoantibody status (ANCA), and four candidate genes are targets of therapies in development, supporting their exploration in EGPA.
Journal ArticleDOI

Ficolin-1 is present in a highly mobilizable subset of human neutrophil granules and associates with the cell surface after stimulation with fMLP

TL;DR: It is shown that neutrophils are a major source of ficolin‐1, which can be readily exocytosed by stimulation, and the majority becomes associated with the surface membrane of the cells and can be detected by flow cytometry.
Journal ArticleDOI

Increased circulating levels of proteinase 3 in patients with anti-neutrophilic cytoplasmic autoantibodies-associated systemic vasculitis in remission.

TL;DR: It is found that levels of proteinase 3 (PR3), one of the main ANCA antigens, are increased in patients with active disease, regardless of ANCA specificity, and this was not due to decreased renal function, ongoing inflammation or neutrophil activation.